Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...

Artemisinin and its derivatives, β-arteether and sodium artesunic acid, have been evaluated for activity against experimental primary amebic meningoencephalitis and the efficacy of these compounds has ...

Artemisinin and Derivatives Market to Reach $200 Million by 2025, Driven by Expanded Malaria Eradication Programs and Emerging Therapeutic Applications The global Artemisinin and Derivatives Market is ...

SAN ANTONIO -- July 27, 2020 -- Southwest Research Institute (SwRI) and The Uni-versity of Texas at San Antonio (UTSA) are working to synthesize novel highly potent derivatives of the antimalarial ...

Resistance to artemisinin, the main component of the current antimalarial treatments recommended by WHO, is already widespread in South-East Asia, but it had not previously been described in Africa.

You have full access to this article via your institution. After years of effort, SM934 was approved in 2015 by the Chinese Food and Drug Administration for phase I/II/III clinical trials for SLE ...

Researchers have demonstrated how the parasite Plasmodium falciparum, which causes severe forms of malaria, is able to circumvent the action of artemisinin and its derivatives, which are today the ...

To slow artemisinin resistance and reduce treatment failures, an international research team investigated various drug policy interventions in Rwanda, where artemisinin resistance was first reported ...

Artemisinin, a sesquiterpene lactone derived from Artemisia annua, has long been recognised for its antimalarial properties and is now under increasing scrutiny for its potential anticancer effects.

The active ingredient dihydroartemisinin may offer a new treatment approach for polycystic ovary syndrome (PCOS), according to a study published in Science by researchers from China. However, PCOS ...

Southwest Research Institute (SwRI) and The Uni-versity of Texas at San Antonio (UTSA) are working to synthesize novel highly potent derivatives of the antimalarial drug artemisinin with the goal of ...